Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (9)
  • 2025 (6)

Subject

  • Drug Trafficking (58)
  • Arrests/Convictions - Major (50)
  • Task Forces/Task Force Officers (37)
  • Synthetic drugs (32)
  • Seizures (Drugs/Property) (31)
  • Major Law Enforcement Operation (30)
  • Guns/Weapons (28)
  • Fentanyl Free America (24)
  • Fentanyl Awareness (14)
  • Diversion Division (13)
  • Fake Pills (13)
  • Counterfeit Pills (10)
  • Money Laundering (9)
  • Outreach/Drug Prevention (8)
  • Press Conferences (8)
  • Take Back Day (8)
  • One Pill Can Kill (7)
  • Pharmaceuticals/Pharmacists/Physicians (7)
  • Overdose (6)
  • Cartel (5)
  • Extraditions (5)
  • OCDETF/Task Force (5)
  • Terrorism (5)
  • Campaigns (4)
  • Public and Media Affairs - also see Congressional Affairs (4)
  • Gangs (3)
  • International/Foreign Operations (3)
  • Other (3)
  • Narcoterrorism (2)
  • Prevention/Education - DEA websites GSAD, JTT etc (2)
  • Critical Incident (1)
  • Intelligence Division - Intelligence Products (1)
  • Intergovernmental Affairs (1)
  • Museum and Visitors Center (1)
  • Red Ribbon (1)
  • Prescription Drugs (15)

Drug Name

  • Oxycodone (3)
  • Cocaine (2)
  • Fentanyl (2)
  • Methamphetamine (2)
  • Heroin (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)

Field Division

  • Atlanta (3)
  • Caribe (1)
  • Dallas (1)
  • Detroit (1)
  • El Paso (6)
  • Los Angeles (4)
  • Louisville (13)
  • Miami (7)
  • New England (6)
  • New Jersey (2)
  • New Orleans (3)
  • New York (7)
  • Omaha (7)
  • Phoenix (4)
  • Rocky Mountain (3)
  • San Diego (1)
  • San Francisco (9)
  • Seattle (10)
  • Sede (8)
  • St. Louis (5)
  • Tampa (2)
  • Washington, DC (4)
Clear All Results
View Archived Press Releases
15 Results - Showing 1 to 10
PRESS RELEASE

Walmart Agrees to Pay $50 Million for Illegally Filling Unlawful Opioid Prescriptions

Washington, D.C. — The Justice Department, together with the Drug Enforcement Administration (DEA), today announced a $50 million settlement with Walmart Inc. (Walmart) to resolve allegations that Walmart pharmacies illegally filled thousands of invalid prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act (CSA). “This...
PRESS RELEASE

Digital Health Company Founder/CEO & Clinical President Sentenced in $100M Adderall Distribution and Health Care Fraud Scheme

NEW YORK – United States Drug Enforcement Administration (“DEA”) Administrator Terrance Cole, DEA Northeast Associate Chief of Operations Frank Tarentino, DEA New York Enforcement Division Special Agent in Charge Farhana Islam, DEA San Francisco Division Special Agent in Charge Bob Beris, along with our law enforcement partners Homeland Security Investigations...
PRESS RELEASE

Founder/CEO and Clinical President of Digital Health Company Sentenced for $90 Million Scheme to Distribute over 37 Million Pills of Adderall

Washington, D.C - The founder and former Chief Executive Officer (CEO) Ruthia He of Done Global Inc., a California-based digital mental health company, was sentenced today to six years in prison and a fine of $1 million for orchestrating a scheme that used her company’s technology platform, compensation structure, and...
PRESS RELEASE

Warren County Physician and Nurse Practitioner Barred from DEA Registration for 20 Years For Prescribing Opioids Unlawfully

ALBANY, NEW YORK – Dr. Douglas Cline and nurse practitioner Laurie McKenna have agreed to pay $500,000 to resolve civil actions brought by the United States involving unlawful opioid prescribing practices and a fraudulent conveyance action against Dr. Cline, announced Drug Enforcement Administration New York Enforcement Division, Special Agent in...
PRESS RELEASE

Brooklyn Woman Charged with Attempting to Steal Opioid Prescriptions from Hempstead Assisted Living Facility

MINEOLA, N.Y. – DEA New York Enforcement Division Special Agent in Charge Farhana Islam and Nassau County District Attorney Anne T. Donnelly announced that a Brooklyn woman was charged with attempted criminal possession of a controlled substance and forgery for allegedly sending falsified oxycodone prescriptions to a pharmacy to obtain...
PRESS RELEASE

Texas Doctor Convicted for Illegally Distributing More than a Million Pills

WASHINGTON D.C. - A federal jury in the Southern District of Texas convicted a Texas physician yesterday for unlawfully distributing more than a million pills of opioids and other dangerous controlled substances. “Medical physicians who exploit their prescribing authority for profit over patient care break an inherent trust with their...
PRESS RELEASE

Glen Head Doctor and His Son Charged with Illegally Selling Prescriptions for Controlled Substances

MINEOLA, N.Y. – Drug Enforcement Administration New York Enforcement Division Special Agent in Charge Farhana Islam and Nassau County District Attorney Anne T. Donnelly announced that a Glen Head doctor and his son were charged with allegedly selling dozens of prescriptions for opioids, amphetamines, and benzodiazepines without a legitimate medical...
PRESS RELEASE

DEA Releases 2026 Aggregate Production Quotas

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...
PRESS RELEASE

Pill Press Machines, Over 16lbs of Alleged Fentanyl, Meth, Cocaine and Oxycodone Recovered in Queens: Three Arrested

Queens, N.Y. - Three men were charged with participating in a narcotics trafficking operation following an investigation that ran for several months and resulted in the seizure of three illegal pill pressing machines and over four kilograms (10 pounds) of fentanyl in powder and pill form from a residence in...
PRESS RELEASE

DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care

WASHINGTON – The U.S. Drug Enforcement Administration, in partnership with the Department of Health and Human Services (HHS), has issued a Fourth Temporary Extension of the COVID-19 Telemedicine Flexibilities for the Prescription of Controlled Medications , extending the current telemedicine flexibilities through December 31, 2026. Under these telemedicine flexibilities, DEA-registered...

Paginación

  • Current page 1
  • Page 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster